Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4171911
Max Phase: Preclinical
Molecular Formula: C47H54N8O5
Molecular Weight: 811.00
Molecule Type: Small molecule
Associated Items:
ID: ALA4171911
Max Phase: Preclinical
Molecular Formula: C47H54N8O5
Molecular Weight: 811.00
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CN[C@H](Cc1ccccc1)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(N)=O
Standard InChI: InChI=1S/C47H54N8O5/c1-29(2)22-38(43(48)56)52-46(59)41(25-32-27-50-36-20-12-10-18-34(32)36)55-45(58)40(24-31-16-8-5-9-17-31)53-47(60)42(26-33-28-51-37-21-13-11-19-35(33)37)54-44(57)39(49-3)23-30-14-6-4-7-15-30/h4-21,27-29,38-42,49-51H,22-26H2,1-3H3,(H2,48,56)(H,52,59)(H,53,60)(H,54,57)(H,55,58)/t38-,39+,40-,41+,42+/m0/s1
Standard InChI Key: DRYABMBZFPAGHW-CTLZPSQBSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 811.00 | Molecular Weight (Monoisotopic): 810.4217 | AlogP: 3.98 | #Rotatable Bonds: 20 |
Polar Surface Area: 203.10 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 8 |
#RO5 Violations: 2 | HBA (Lipinski): 13 | HBD (Lipinski): 9 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.94 | CX Basic pKa: 8.34 | CX LogP: 4.98 | CX LogD: 3.99 |
Aromatic Rings: 6 | Heavy Atoms: 60 | QED Weighted: 0.06 | Np Likeness Score: 0.04 |
1. Haitham Abusara O, Freeman S, Aojula HS.. (2017) Pentapeptides for the treatment of small cell lung cancer: Optimisation by Nind-alkyl modification of the tryptophan side chain., 137 [PMID:28595067] [10.1016/j.ejmech.2017.05.053] |
Source(1):